HOLX
Hologic, Inc. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q1 2026 | 150 | -11 | 142.41M | $10.76B | n/a | −12 |
| Q4 2025 | 160 | -1 | 162.64M | $12.11B | +3 | −3 |
| Q3 2025 | 23 | 0 | 82.82M | $5.59B | +1 | −2 |
| Q2 2025 | 21 | +4 | 78.04M | $5.08B | +4 | n/a |
| Q1 2025 | 14 | -1 | 24.06M | $1.49B | n/a | −1 |
| Q4 2024 | 15 | 0 | 25.76M | $1.86B | n/a | n/a |
| Q3 2024 | 14 | -1 | 17.19M | $1.40B | n/a | −1 |
| Q2 2024 | 15 | n/a | 21.25M | $1.58B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 5.88M | n/a | $436.31M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passive) | 5.57M | n/a | $412.75M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Renaissance Technologies ✦ | 2.54M | n/a | $188.88M | 0.3% | n/c | 1 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 2.42M | n/a | $180.03M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 1.19M | n/a | $88.63M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 6 | Arrowstreet Capital ✦ | 1.09M | n/a | $80.78M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 806.34K | n/a | $59.87M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 565.96K | n/a | $42.02M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 9 | Marshall Wace ✦ | 531.00K | n/a | $39.43M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 10 | Bridgewater Associates ✦ | 317.33K | n/a | $23.56M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 221.29K | n/a | $16.43M | 0.2% | n/c | 1 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 54.39K | n/a | $4.04M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 45.42K | n/a | $3.37M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Fisher Asset Management ✦ | 8.79K | n/a | $652,764 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 2.38K | n/a | $176,715 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 699 holders, 212.67M shares, $15.33B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.